Related Experiment Video

Updated: Jun 24, 2026

Imaging the Intracellular Trafficking of APP with Photoactivatable GFP
07:55

Imaging the Intracellular Trafficking of APP with Photoactivatable GFP

Published on: October 17, 2015

Site-directed mutations in the C-terminal extension of human alphaB-crystallin affect chaperone function and block

Teresa M Treweek1, Heath Ecroyd, Danielle M Williams

  • 1Department of Chemistry, University of Wollongong, Wollongong, New South Wales, Australia.

Plos One
|October 18, 2007
PubMed
Abstract

Insights

Modifying the C-terminal region of alphaB-crystallin, a molecular chaperone, enhances its ability to prevent amyloid fibril formation. This engineered chaperone shows improved activity against protein aggregation implicated in neurodegenerative diseases.

Area of Science:

  • Biochemistry
  • Molecular Biology
  • Neuroscience

Background:

  • Neurodegenerative diseases like Alzheimer's and Parkinson's are linked to abnormal protein aggregation into amyloid fibrils.
  • Molecular chaperones, such as alphaB-crystallin, are crucial in preventing protein misfolding and deposition.

Purpose of the Study:

  • To investigate the structural and functional roles of the C-terminal extension of human alphaB-crystallin.
  • To assess the impact of mutations in this region on chaperone activity against different protein aggregation types.

Main Methods:

  • Site-directed mutagenesis was used to create alphaB-crystallin variants targeting the C-terminal extension.
  • Chaperone activity was evaluated using models of both disordered amorphous aggregation and ordered amyloid fibril assembly.

Main Results:

  • Mutations in lysine and glutamic acid residues of the C-terminal extension significantly improved alphaB-crystallin's chaperone activity.
  • Enhanced activity was particularly noted against amyloid fibril-forming proteins compared to wild-type alphaB-crystallin.

Conclusions:

  • The C-terminal region of alphaB-crystallin is critical for regulating its structure, stability, and chaperone function.
  • Genetically engineered alphaB-crystallin with enhanced anti-amyloid activity presents a potential therapeutic strategy for amyloid-related diseases.

More Related Videos

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging09:37

A Phenotyping Regimen for Genetically Modified Mice Used to Study Genes Implicated in Human Diseases of Aging

Published on: July 14, 2016

Saccharomyces cerevisiae Models of Alzheimer's Disease to Screen Genes, Mutations, and Chemicals Affecting Amyloid Beta Production by γ-Secretase11:57

Saccharomyces cerevisiae Models of Alzheimer's Disease to Screen Genes, Mutations, and Chemicals Affecting Amyloid Beta Production by γ-Secretase

Published on: June 24, 2025

Related Concept Videos

Mutations01:39

Mutations

Overview
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...
Amyloid Fibrils03:03

Amyloid Fibrils

Amyloid fibrils are aggregates of misfolded proteins.  Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils. 
Amyloid deposits were observed as early as 1639 in the liver and the spleen.   In 1854, Rudolph Virchow performed iodine staining, normally used to...